Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer

Despite the promising outcomes of immune checkpoint blockade (ICB), resistance to ICB presents a new challenge. Therefore, selecting patients for specific ICB applications is crucial for maximizing therapeutic efficacy. Herein we curated 69 human esophageal squamous cell cancer (ESCC) patients’ tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Kyung-Pil, Zhang, Shengzhe, Huang, Yuanjian, Kim, Bongjun, Zou, Gengyi, Jun, Sohee, Zhang, Jie, Martin, Cecilia, Dunbar, Karen J., Efe, Gizem, Rustgi, Anil K., Zhang, Haiyang, Nakagawa, Hiroshi, Park, Jae-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949073/
https://www.ncbi.nlm.nih.gov/pubmed/36824935
http://dx.doi.org/10.1101/2023.02.15.528539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949073/
https://www.ncbi.nlm.nih.gov/pubmed/36824935
http://dx.doi.org/10.1101/2023.02.15.528539

Ejemplares similares